Table 3 Risk behavior reported at the first and last test in individuals undergoing repeat HIV testing: individuals with <180 days between tests were excluded
2–3 HIV tests (n = 1384; 47 HIV+) median time first/last test 503 days (IQR, 317–845 days) | 4–5 HIV tests (n = 565; 22 HIV+) median time first/last test 844 days (IQR, 567–1229 days) | 6 or more tests (n = 508; 18 HIV+) median time first/last test 1333 days (IQR, 920–1705 days) | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Risk factor/risk behavior (within 12 months prior to test) | Prevalence of AEH per individuals that reported the risk a | First Test | Last Test | First Test | Last Test | First Test | Last Test | ||||||
Individuals reporting risk (n,%) | Individuals reporting risk (n, %) | Difference in percentage, relative (absolute) | P value b | Individuals reporting risk (n, %) | Individuals reporting risk (n, %) | Difference in percentage, relative (absolute) | P value b | Individuals reporting risk (n, %) | Individuals reporting risk (n, %) | Difference in percentage, relative (absolute) | P value b | ||
10 or more male partners | 3.8 % | 456/1384 (32.95 %) | 504/1384 (36.42 %) | +10.53 % (+3.47 %) | 0.011 | 193/565 (34.16 %) | 224/565 (39.65 %) | +16.07 % (+5.49 %) | 0.012 | 198/508 (38.98 %) | 223/508 (43.90 %) | +12.62 % (+4.92 %) | 0.054 |
CRAI and 10 or more male partners | 5.5 % | 255/1384 (18.43 %) | 301/1384 (21.75 %) | +18.01 % (+3.32 %) | 0.006 | 101/565 (17.88 %) | 132/565 (23.36 %) | +30.65 % (+5.48 %) | 0.004 | 116/508 (22.83 %) | 130/508 (25.59 %) | +12.09 % (+2.76 %) | n.s. |
CRAI with HIV positive male | 7.8 % | 46/1277 (3.60 %) | 72/1335 (5.39 %) | +49.72 % (+1.79 %) | n.s. | 18/526 (3.42 %) | 32/551 (5.81 %) | +69.88 % (+2.39 %) | n.s. | 8/446 (1.79 %) | 52/495 (10.51 %) | +487 % (+8.72 %) | <0.001 |
CRAI with sex worker | 7.7 % | 5/1350 (0.37 %) | 6/1364 (0.44 %) | +10.45 % (+0.07 %) | n.s. | 1/555 (0.18 %) | 2/561 (0.36 %) | +100 % (+0.18 %) | n.s. | 1/489 (0.20 %) | 4/502 (0.80 %) | +300 % (+0.60 %) | n.s. |
CRAI with PWID | 10.3 % | 9/1350 (0.67 %) | 17/1365 (1.25 %) | +86.57 % (+0.58 %) | n.s. | 5/555 (0.90 %) | 13/559 (2.33 %) | +159 % (+1.43 %) | n.s. | 0/491 (0 %) | 9/498 (1.81 %) | +∞ (+1.81 %) | 0.008 |
Any self-reported STI | 4.6 % | 155/1384 (11.20 %) | 177/1384 (12.79 %) | +14.20 % (+1.59 %) | n.s. | 64/565 (11.33 %) | 87/565 (15.40 %) | +35.92 % (+4.07 %) | 0.040 | 91/508 (17.91 %) | 77/508 (15.16 %) | −15.35 % (−2.75 %) | n.s. |
IDU with shared needles | 7.8 % | 4/1384 (0.29 %) | 9/1384 (0.65 %) | +124 % (+0.36 %) | n.s. | 2/565 (0.35 %) | 5/555 (0.90 %) | +157 % (+0.55 %) | n.s. | 0/508 (0 %) | 3/508 (0.59 %) | +∞ (+0.59 %) | n.s. |
Methamphetamine, not injected | 6.2 % | 77/1384 (5.56 %) | 88/1384 (6.36 %) | +14.39 % (+0.80 %) | n.s. | 28/565 (4.96 %) | 35/565 (6.19 %) | +24.79 % (+1.23 %) | n.s. | 26/508 (5.11 %) | 38/508 (7.48 %) | +46.38 % (+2.37 %) | 0.090 |
Non-injection stimulant drug use c | 3.3 % | 318/1384 (22.98 %) | 411/1384 (29.70 %) | +29.24 % (+6.72 %) | <0.001 | 130/565 (23.01 %) | 166/565 (29.38 %) | +27.58 % (+6.37 %) | 0.002 | 96/508 (18.90 %) | 163/508 (32.09 %) | +69.79 % (+13.19 %) | <0.001 |